Report Shows US CBD Sales Will Exceed $1 Billion in 2019

October 21, 2019 08:00:25

The Farm Bill signed in December 2018 was, without a doubt, a game-changer. The bill legalized the cultivation of industrial hemp, which is known for producing high concentrations of cannabidiol (CBD) and only trace amounts of THC. THC is the primary psychotropic agent, and it’s what gives users the out of body high.

CBD is non-psychotropic, and it’s known for the plethora of benefits it affords its users. For the past decade or so, CBD has become a lot more mainstream, and more people are now aware of its health benefits. Living as we are in a time when people prize clean, natural remedies, the explosive demand for CBD was almost…

Read More >>

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com